Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Acrivon Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20
Revenues13.71.9
            Revenue growth622.3% 
Cost of goods sold16.23.2
Gross profit-2.4-1.3
            Gross margin-17.8%-66.6%
General and administrative2.51.3
EBIT-16.2-3.2
            EBIT margin-117.8%-166.6%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)4,299.23,532.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy